Biofluidica Announces $6 Million Series B2 Funding To Support The Commercialization Of Its Liquid Biopsy Microfluidics Platform, The Liquidscan™, And The Development Of Its Advanced Handheld Covid-19 Detection Device For Consumer At-Home Testing
Amount Raised
$6 Million
Round Type
Series B
San DiegoDescription
BioFluidica, Inc., a biotechnology company developing a diagnostic platform allowing for disease management and diagnosis, today announced that it has raised over $6 million in the initial closings of its Series B2 financing. Additional closings in this targeted $10 million financing are anticipated following successful completion of development milestones relating to BioFluidica's handheld infectious disease detection device using nanofluidics for ultrafast high-sensitivity detection of virus particles. The funding round was led by BioFluidica's existing investor base, with participation from new investors.
Quick answer
Bio Fluidica raised $6 Million in a Series B round, dated February 8, 2022. Bio Fluidica is based in San Diego, California, United States.
- How much did Bio Fluidica raise?
- Bio Fluidica raised $6 Million in a Series B round on February 8, 2022.
- What does Bio Fluidica do?
- BioFluidica is a privately held biotechnology company that has developed a revolutionary liquid biopsy platform allowing for isolation and analysis of all liquid biopsy biomarkers including cells, exosomes and cfDNA on..
- Where is Bio Fluidica based and how big is it?
- Bio Fluidica is based in San Diego, California, United States.
Source: Fundz verified event record.
Who to call at Bio Fluidica, and when
A new round usually means Bio Fluidica is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bio Fluidica raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bio Fluidica, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bio Fluidica. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bio Fluidica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansBio Fluidica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.